Loading…

Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus

Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2004-04, Vol.109 (4), p.483-490
Main Authors: Takeuchi, Hiroya, Ozawa, Soji, Shih, Chih‐Horng, Ando, Nobutoshi, Kitagawa, Yuko, Ueda, Masakazu, Kitajima, Masaki
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203
cites cdi_FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203
container_end_page 490
container_issue 4
container_start_page 483
container_title International journal of cancer
container_volume 109
creator Takeuchi, Hiroya
Ozawa, Soji
Shih, Chih‐Horng
Ando, Nobutoshi
Kitagawa, Yuko
Ueda, Masakazu
Kitajima, Masaki
description Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis and tumor progression in ESCC. We hypothesized that VEGF expression in ESCC is reflected by abnormalities in the p16 INK4a gene. To clarify the regulatory role of p16 INK4a in VEGF expression in vitro , we transferred the p16 INK4a gene into a p16 INK4a ‐deleted ESCC cell line and observed changes in VEGF expression. Furthermore, we immunohistochemically assessed the expression of the cell cycle regulators (p16, p53 and RB) and VEGF in 90 surgically resected specimens of ESCC. Introduction of p16 INK4a cDNA by the p16 expression vector significantly suppressed cell proliferation in the p16 INK4a ‐deleted cell line TE8 ( p < 0.0001). VEGF secretion by TE8 cells transfected with the p16 INK4a vector was significantly suppressed as compared to non‐transfected TE8 cells ( p < 0.0001) and TE8 cells transfected with a control vector ( p = 0.0015). The immunohistochemical studies of ESCC primary tumor specimens showed that loss of p16 expression was significantly correlated with VEGF‐positive expression ( p = 0.0004). The cumulative postoperative survival rate in the group with p16‐positive and VEGF‐negative expression was significantly higher than in the other groups. Neither p53 nor RB expression had any impact on outcome. Aberrant p53 expression tended to be associated with VEGF expression, but the trend did not reach statistical significance. Our study demonstrated that VEGF expression was correlated with p16 expression in ESCC. Our results suggest that p16 may have a regulatory role in VEGF expression in ESCC. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ijc.11734
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ijc_11734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_ijc_11734</sourcerecordid><originalsourceid>FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203</originalsourceid><addsrcrecordid>eNpVkL1Ow0AQhE8IJEKg4A2upXDYs8--uEQRPxERNOmt9fqcXOT4zK1N4BF4axygoZpiNDOaT4hrBTMFEN-6Hc2UMok-ERMFuYkgVumpmIweREYl2bm4YN4BKJWCnoivlWeWvpadyuTy5VmjtB9dsMzOt9KxRGZPDntbyYPrt_IdmYYGg7Rt5futbRw2chP8YfRqpN6HfwWt5LcB935gSbZpJGEg1_o9HjfHuLTsuy1uBr4UZzU2bK_-dCrWD_frxVO0en1cLu5WERmtoxKxBEpNHptyXkNlasq1BlOZBG1GuY0NaSCbQoJUxnmazucpEmQlZfXIIJmKm99aCuPzYOuiC26P4bNQUBwRFiPC4gdh8g2SNWcd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Takeuchi, Hiroya ; Ozawa, Soji ; Shih, Chih‐Horng ; Ando, Nobutoshi ; Kitagawa, Yuko ; Ueda, Masakazu ; Kitajima, Masaki</creator><creatorcontrib>Takeuchi, Hiroya ; Ozawa, Soji ; Shih, Chih‐Horng ; Ando, Nobutoshi ; Kitagawa, Yuko ; Ueda, Masakazu ; Kitajima, Masaki</creatorcontrib><description>Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis and tumor progression in ESCC. We hypothesized that VEGF expression in ESCC is reflected by abnormalities in the p16 INK4a gene. To clarify the regulatory role of p16 INK4a in VEGF expression in vitro , we transferred the p16 INK4a gene into a p16 INK4a ‐deleted ESCC cell line and observed changes in VEGF expression. Furthermore, we immunohistochemically assessed the expression of the cell cycle regulators (p16, p53 and RB) and VEGF in 90 surgically resected specimens of ESCC. Introduction of p16 INK4a cDNA by the p16 expression vector significantly suppressed cell proliferation in the p16 INK4a ‐deleted cell line TE8 ( p &lt; 0.0001). VEGF secretion by TE8 cells transfected with the p16 INK4a vector was significantly suppressed as compared to non‐transfected TE8 cells ( p &lt; 0.0001) and TE8 cells transfected with a control vector ( p = 0.0015). The immunohistochemical studies of ESCC primary tumor specimens showed that loss of p16 expression was significantly correlated with VEGF‐positive expression ( p = 0.0004). The cumulative postoperative survival rate in the group with p16‐positive and VEGF‐negative expression was significantly higher than in the other groups. Neither p53 nor RB expression had any impact on outcome. Aberrant p53 expression tended to be associated with VEGF expression, but the trend did not reach statistical significance. Our study demonstrated that VEGF expression was correlated with p16 expression in ESCC. Our results suggest that p16 may have a regulatory role in VEGF expression in ESCC. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.11734</identifier><language>eng</language><ispartof>International journal of cancer, 2004-04, Vol.109 (4), p.483-490</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203</citedby><cites>FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Takeuchi, Hiroya</creatorcontrib><creatorcontrib>Ozawa, Soji</creatorcontrib><creatorcontrib>Shih, Chih‐Horng</creatorcontrib><creatorcontrib>Ando, Nobutoshi</creatorcontrib><creatorcontrib>Kitagawa, Yuko</creatorcontrib><creatorcontrib>Ueda, Masakazu</creatorcontrib><creatorcontrib>Kitajima, Masaki</creatorcontrib><title>Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus</title><title>International journal of cancer</title><description>Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis and tumor progression in ESCC. We hypothesized that VEGF expression in ESCC is reflected by abnormalities in the p16 INK4a gene. To clarify the regulatory role of p16 INK4a in VEGF expression in vitro , we transferred the p16 INK4a gene into a p16 INK4a ‐deleted ESCC cell line and observed changes in VEGF expression. Furthermore, we immunohistochemically assessed the expression of the cell cycle regulators (p16, p53 and RB) and VEGF in 90 surgically resected specimens of ESCC. Introduction of p16 INK4a cDNA by the p16 expression vector significantly suppressed cell proliferation in the p16 INK4a ‐deleted cell line TE8 ( p &lt; 0.0001). VEGF secretion by TE8 cells transfected with the p16 INK4a vector was significantly suppressed as compared to non‐transfected TE8 cells ( p &lt; 0.0001) and TE8 cells transfected with a control vector ( p = 0.0015). The immunohistochemical studies of ESCC primary tumor specimens showed that loss of p16 expression was significantly correlated with VEGF‐positive expression ( p = 0.0004). The cumulative postoperative survival rate in the group with p16‐positive and VEGF‐negative expression was significantly higher than in the other groups. Neither p53 nor RB expression had any impact on outcome. Aberrant p53 expression tended to be associated with VEGF expression, but the trend did not reach statistical significance. Our study demonstrated that VEGF expression was correlated with p16 expression in ESCC. Our results suggest that p16 may have a regulatory role in VEGF expression in ESCC. © 2004 Wiley‐Liss, Inc.</description><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpVkL1Ow0AQhE8IJEKg4A2upXDYs8--uEQRPxERNOmt9fqcXOT4zK1N4BF4axygoZpiNDOaT4hrBTMFEN-6Hc2UMok-ERMFuYkgVumpmIweREYl2bm4YN4BKJWCnoivlWeWvpadyuTy5VmjtB9dsMzOt9KxRGZPDntbyYPrt_IdmYYGg7Rt5futbRw2chP8YfRqpN6HfwWt5LcB935gSbZpJGEg1_o9HjfHuLTsuy1uBr4UZzU2bK_-dCrWD_frxVO0en1cLu5WERmtoxKxBEpNHptyXkNlasq1BlOZBG1GuY0NaSCbQoJUxnmazucpEmQlZfXIIJmKm99aCuPzYOuiC26P4bNQUBwRFiPC4gdh8g2SNWcd</recordid><startdate>20040420</startdate><enddate>20040420</enddate><creator>Takeuchi, Hiroya</creator><creator>Ozawa, Soji</creator><creator>Shih, Chih‐Horng</creator><creator>Ando, Nobutoshi</creator><creator>Kitagawa, Yuko</creator><creator>Ueda, Masakazu</creator><creator>Kitajima, Masaki</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20040420</creationdate><title>Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus</title><author>Takeuchi, Hiroya ; Ozawa, Soji ; Shih, Chih‐Horng ; Ando, Nobutoshi ; Kitagawa, Yuko ; Ueda, Masakazu ; Kitajima, Masaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeuchi, Hiroya</creatorcontrib><creatorcontrib>Ozawa, Soji</creatorcontrib><creatorcontrib>Shih, Chih‐Horng</creatorcontrib><creatorcontrib>Ando, Nobutoshi</creatorcontrib><creatorcontrib>Kitagawa, Yuko</creatorcontrib><creatorcontrib>Ueda, Masakazu</creatorcontrib><creatorcontrib>Kitajima, Masaki</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeuchi, Hiroya</au><au>Ozawa, Soji</au><au>Shih, Chih‐Horng</au><au>Ando, Nobutoshi</au><au>Kitagawa, Yuko</au><au>Ueda, Masakazu</au><au>Kitajima, Masaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus</atitle><jtitle>International journal of cancer</jtitle><date>2004-04-20</date><risdate>2004</risdate><volume>109</volume><issue>4</issue><spage>483</spage><epage>490</epage><pages>483-490</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis and tumor progression in ESCC. We hypothesized that VEGF expression in ESCC is reflected by abnormalities in the p16 INK4a gene. To clarify the regulatory role of p16 INK4a in VEGF expression in vitro , we transferred the p16 INK4a gene into a p16 INK4a ‐deleted ESCC cell line and observed changes in VEGF expression. Furthermore, we immunohistochemically assessed the expression of the cell cycle regulators (p16, p53 and RB) and VEGF in 90 surgically resected specimens of ESCC. Introduction of p16 INK4a cDNA by the p16 expression vector significantly suppressed cell proliferation in the p16 INK4a ‐deleted cell line TE8 ( p &lt; 0.0001). VEGF secretion by TE8 cells transfected with the p16 INK4a vector was significantly suppressed as compared to non‐transfected TE8 cells ( p &lt; 0.0001) and TE8 cells transfected with a control vector ( p = 0.0015). The immunohistochemical studies of ESCC primary tumor specimens showed that loss of p16 expression was significantly correlated with VEGF‐positive expression ( p = 0.0004). The cumulative postoperative survival rate in the group with p16‐positive and VEGF‐negative expression was significantly higher than in the other groups. Neither p53 nor RB expression had any impact on outcome. Aberrant p53 expression tended to be associated with VEGF expression, but the trend did not reach statistical significance. Our study demonstrated that VEGF expression was correlated with p16 expression in ESCC. Our results suggest that p16 may have a regulatory role in VEGF expression in ESCC. © 2004 Wiley‐Liss, Inc.</abstract><doi>10.1002/ijc.11734</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2004-04, Vol.109 (4), p.483-490
issn 0020-7136
1097-0215
language eng
recordid cdi_crossref_primary_10_1002_ijc_11734
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
title Loss of p16 INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T16%3A03%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20p16%20INK4a%20expression%20is%20associated%20with%20vascular%20endothelial%20growth%20factor%20expression%20in%20squamous%20cell%20carcinoma%20of%20the%20esophagus&rft.jtitle=International%20journal%20of%20cancer&rft.au=Takeuchi,%20Hiroya&rft.date=2004-04-20&rft.volume=109&rft.issue=4&rft.spage=483&rft.epage=490&rft.pages=483-490&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.11734&rft_dat=%3Ccrossref%3E10_1002_ijc_11734%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c744-baab0c57927b8f0d7fc94407d73ae6c9e27c40ce503acb2955885ac06bc6f0203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true